1. A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis. Issue 6 (December 2013) Authors: Cosgrove, Sallie B.; Wren, Jody A.; Cleaver, Dawn M.; Walsh, Kelly F.; Follis, Stacey I.; King, Vickie I.; Tena, Jezaniah‐Kira S.; Stegemann, Michael R. Journal: Veterinary dermatology Issue: Volume 24:Issue 6(2013:Dec.) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗